Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.
SUNY College of Optometry’s Dr. Alexandra Benavente-Pérez was awarded a grant that will explore the unknown nature of the relationship between myopia (nearsightedness) and glaucoma by focusing on their effect on the ganglion cell complex.
Use of low-dose atropine eyedrops (concentration 0.01%) was no better than placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years
A new study suggests that eye drops developed by Columbia University researchers could be a more effective–and comfortable–therapy for a common eye disease currently treated with injections into the eye.
A Northwestern Medicine study has uncovered novel cellular mechanisms within the retina, findings that could help advance the development of targeted therapeutics for diseases and conditions affecting vision.
Three-dimensional, lab-grown “mini-corneas” resemble the developing human cornea, making them a powerful new tool for the study of corneal diseases, a study finds.
Repeat treatment with corticosteroid injections improved vision in people with persistent or recurrent uveitis-related macular edema better than two other therapies, according to results from a clinical trial funded by the National Eye Institute (NEI).
Representatives from a dozen global organizations and as many countries launched a new collaboration with the National Eye Institute aimed at advancing vision research and eye heath globally
UConn School of Medicine researchers report that a small population of nerve cells exist in everyone that could be coaxed to regrow, potentially restoring sight and movement after injury.